The Spring 2012 edition of Emory's Public Health Magazine features an article on Keith Klugman and the first-ever drug resistance index (DRI). Much like a stock market or consumer price index, the DRI aggregates and weights available data to produce a single measure that can be examined over time - in this case the index represents the burden of resistance in a hospital or geographical area. Why create this
Extending the Cure director Ramanan Laxminarayan weighs in on the landscape of hospital infection control in a recent commentary for PNAS. The commentary is in response to a study by Ke et al that shows how increasing patient sharing leads to decreased heterogeneity of MRSA strains among medical facilities.
Yesterday, the FDA took another step towards restricting the use of antimicrobials in farm animals in the United States, finalizing guidance for farmers and drug companies to begin voluntarily phasing out the drugs.